Alphatec Holdings [ATEC] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Alphatec Holdings Inc.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Alphatec Holdings Inc. wins in 4 metrics, Abbott Laboratories wins in 14 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Alphatec Holdings Inc. Abbott Laboratories Better
P/E Ratio (TTM) -10.64 25.97 Abbott Laboratories
Price-to-Book Ratio 126.27 3.09 Abbott Laboratories
Debt-to-Equity Ratio 1,654.48 26.79 Abbott Laboratories
PEG Ratio 0.27 -1.41 Alphatec Holdings Inc.
EV/EBITDA 104.74 13.74 Abbott Laboratories
Profit Margin (TTM) -18.76% 13.90% Abbott Laboratories
Operating Margin (TTM) -2.52% 16.50% Abbott Laboratories
EBITDA Margin (TTM) N/A 16.50% N/A
Return on Equity -630.66% 12.36% Abbott Laboratories
Return on Assets (TTM) -4.62% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-4.41M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return -25.14% -34.98% Alphatec Holdings Inc.
Price-to-Sales Ratio (TTM) 2.08 3.57 Alphatec Holdings Inc.
Enterprise Value $2.05B $166.96B Abbott Laboratories
EV/Revenue Ratio 2.68 3.70 Alphatec Holdings Inc.
Gross Profit Margin (TTM) 70.21% N/A N/A
Revenue per Share (TTM) $5 $26 Abbott Laboratories
Earnings per Share (Diluted) $-0.96 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.12 0.78 Abbott Laboratories
Short % of Float 11.92% 1.53% Abbott Laboratories

Alphatec Holdings Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

ATEC
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alphatec Holdings Inc.0.12%4.80%8.22%-34.21%-57.94%-60.07%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alphatec Holdings Inc.-25.14%-46.06%-44.17%200.00%-79.71%-91.29%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: Alphatec Holdings Inc. vs Abbott Laboratories

MetricATECABT
Market Information
Market Cap i$1.55B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,265,84313,495,583
90 Day Avg. Volume i2,302,67812,934,461
Last Close$8.29$88.67
52 Week Range$6.82 - $23.29$81.97 - $139.06
% from 52W High-64.41%-36.24%
All-Time High$105.60 (Jun 12, 2006)$142.60 (Dec 27, 2021)
% from All-Time High-92.15%-37.82%
Growth Metrics
Quarterly Revenue Growth0.20%0.08%
Quarterly Earnings Growth0.20%-0.19%
Financial Health
Profit Margin (TTM) i-0.19%0.14%
Operating Margin (TTM) i-0.03%0.17%
Return on Equity (TTM) i-6.31%0.12%
Debt to Equity (MRQ) i1,654.4826.79
Cash & Liquidity
Book Value per Share (MRQ)$0.08$30.02
Cash per Share (MRQ)$1.06$5.14
Operating Cash Flow (TTM) i$45.23M$10.80B
Levered Free Cash Flow (TTM) i$56.15M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Alphatec Holdings Inc. vs Abbott Laboratories

MetricATEC (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-10.6425.97
Forward P/E i18.2315.29
PEG Ratio i0.27-1.41
Price to Sales (TTM) i2.083.57
Price to Book (MRQ) i126.273.09
Market Capitalization
Market Capitalization i$1.55B$160.70B
Enterprise Value i$2.05B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i2.683.70
Enterprise to EBITDA i104.7413.74
Risk & Other Metrics
Beta i1.120.78
Book Value per Share (MRQ) i$0.08$30.02

Financial Statements Comparison: Alphatec Holdings Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricATEC (2025)ABT (2025)
Revenue/Sales i764.16M44.33B
Cost of Goods Sold i232.27M19.32B
COGS % of Revenue i30.4%43.6%
Gross Profit i531.89M25.01B
Gross Margin i69.6%56.4%
Research & Development i76.27M2.94B
Operating Income (EBIT) i-57.97M8.05B
Operating Margin i-7.6%18.2%
EBITDA i26.20M12.03B
EBITDA Margin i3.4%27.1%
Pre-Tax Income i-143.40M8.47B
Pre-Tax Income % of Revenue i-18.8%19.1%
Income Tax i-45,0001.94B
Income Tax % of Revenue i0.0%4.4%
Net Income (Profit) i-143.36M6.52B
Profit Margin i-18.8%14.7%

Balance Sheet & Liquidity Metrics

MetricATEC (2025)ABT (2025)
Cash & Equivalents i160.81M8.52B
Total Current Assets i450.88M26.00B
Total Current Assets % of Revenue i59.0%58.6%
Total Current Liabilities i219.18M16.50B
Total Current Liabilities % of Revenue i28.7%37.2%
Long-Term Debt i525.27M10.83B
Long-Term Debt % of Revenue i68.7%24.4%
Total Shareholders Equity i12.43M52.77B
Retained Earnings i-1.42B49.78B
Retained Earnings % of Revenue i-186.4%112.3%
Property, Plant & Equipment i342.74M17.57B

Cash Flow Statement Comparison

MetricATEC (2025)ABT (2025)
Operating Cash Flow i-1.80M10.80B
Operating Cash Flow % of Revenue i-0.2%24.4%
Capital Expenditures i-42.46M-2.17B
Free Cash Flow i-4.41M7.40B
FCF Margin i-0.6%16.7%
Debt Repayment i-332.19M-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricATECABT
Shares Short i14.95M23.83M
Short Ratio i6.331.93
Short % of Float i11.92%1.53%
Shares Outstanding i148.45M1.74B
Float Shares i119.02M1.73B
% Held by Insiders i22.18%0.54%
% Held by Institutions i81.03%82.23%
% Held by Public i-3.21%17.23%

Dividend Analysis & Yield Comparison: Alphatec Holdings Inc. vs Abbott Laboratories

MetricATECABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026